References
- Wolfe JN. Breast patterns as an index of risk for developing breast cancer. Am J Roentgenol 1976;126:1130–7
- Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007;356:227–36
- Vachon CM, Sellers TA, Carlson EE, et al. Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. Cancer Res 2007;67:8412–18
- Boyd NF. Mammographic density and risk of breast cancer. Am Soc Clin Oncol Educ Book 2013; (doi: 10.1200/EdBook_AM.2013.33.e57)
- Panay N, Kalu E. Management of premature ovarian failure. Best Pract Res Clin Obstet Gynaecol 2009;23:129–40
- Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–33
- Benetti-Pinto CL, Brancalion MF, Assis LH, et al. Mammographic breast density in women with premature ovarian failure: a prospective analysis. Menopause 2014;21:933–7
- Soares PM, Cabello C, Magna LA, Tinois E, Benetti-Pinto CL. Breast density in women with premature ovarian failure or postmenopausal women using hormone therapy: analytical cross-sectional study. Sao Paulo Med J 2010;128:211–14
- Cabello dos Santos C. Efeitos da terapia de reposição hormonal na densidade mamográfica de mulheres menopausadas. Universidade Estadual de Campinas; 1997. Available from http://www.bibliotecadigital.unicamp.br/document/?code=vtls000121444&opt=4
- Schetter SE. Breast density as an independent risk factor for cancer. J Am Osteopath Coll Radiol 2014;3:10–19
- Shepherd JA, Kerlikowske K, Ma L, et al. Volume of mammographic density and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 2011;20:1473–82
- Noh JJ, Maskarinec G, Pagano I, Cheung LW, Stanczyk FZ. Mammographic densities and circulating hormones: a cross-sectional study in premenopausal women. Breast 2006;15:20–8
- Boyd NF, Byng JW, Jong RA, et al. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst 1995;87:670–5
- Byrne C, Schairer C, Wolfe J, et al. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst 1995;87:1622–9
- Maskarinec G, Meng L. A case-control study of mammographic densities in Hawaii. Breast Cancer Res Treat 2000;63:153–61
- Signori C, DuBrock C, Richie JP, et al. Administration of omega-3 fatty acids and raloxifene to women at high risk of breast cancer: interim feasibility and biomarkers analysis from a clinical trial. Eur J Clin Nutr 2012;66:878–84
- Harvey JA, Bovbjerg VE. Quantitative assessment of mammographic breast density: relationship with breast cancer risk. Radiology 2004;230:29–41
- Caglayan EK, Caglayan K, Alkis I, et al. Factors associated with mammographic density in postmenopausal women. J Menopausal Med 2015;21:82–8
- Schetter SE, Hartman TJ, Liao J, et al. Differential impact of body mass index on absolute and percent breast density: implications regarding their use as breast cancer risk biomarkers. Breast Cancer Res Treat 2014;146:355–63
- Reeves KW, Stone RA, Modugno F, et al. Longitudinal association of anthropometry with mammographic breast density in the Study of Women's Health Across the Nation. Int J Cancer 2009;124:1169–77
- Sung J, Song YM, Stone J, Lee K, Kim SY. Association of body size measurements and mammographic density in Korean women: the Healthy Twin study. Cancer Epidemiol Biomarkers Prev 2010;19:1523–31
- Marchesoni D, Driul L, Ianni A, et al. Postmenopausal hormone therapy and mammographic breast density. Maturitas 2006;53:59–64
- McTiernan A, Martin CF, Peck JD, et al. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial. J Natl Cancer Inst 2005;97:1366–76